Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review

Link to article at PubMed

J Am Coll Cardiol. 2023 Oct 3;82(14):1445-1463. doi: 10.1016/j.jacc.2023.07.024.

ABSTRACT

Many randomized trials in cardiovascular disease have repeat nonfatal events (such as hospitalizations) occurring during patient follow-up; yet, it remains common practice to have time-to-first event as the primary outcome. We explore the value of analyses that include repeat events. Do they help us understand the effect of treatment and total disease burden? Do they enhance statistical power? Should they become a trial's primary analysis? It may also be difficult to choose which of the various statistical methods for analyzing repeat events to use, and we provide a nontechnical guide to what each method is doing. We compare several methods for repeat events: Lin Wei Yang Ying, negative binomial, joint frailty, win ratio, and area under the curve. We illustrate their performance in 5 large cardiovascular trials and compare them with time-to-first-event analyses. We review their use in recently published heart failure trials and make recommendations for their use in future trials.

PMID:37758440 | DOI:10.1016/j.jacc.2023.07.024

Leave a Reply

Your email address will not be published. Required fields are marked *